BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that it will release its financial results for the quarter and year ended December 31, 2012 on Tuesday, March 12, 2013, before the U.S. markets open.
